Insights from TARGET-seq: Inflammation drives TP53-mediated clonal evolution

• Yeqian Zhao,
• Wenxuan Huo,
• Yue Liang,
• Xiaodong Mo,
• Shanshan Pei,
• Yanmin Zhao

Affiliations

Yeqian Zhao

Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou 311121, China; Institute of Hematology, Zhejiang University, Hangzhou 311121, China

Wenxuan Huo

Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China

Yue Liang

Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou 311121, China; Institute of Hematology, Zhejiang University, Hangzhou 311121, China

Xiaodong Mo

Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China; Corresponding author

Shanshan Pei

Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou 311121, China; Institute of Hematology, Zhejiang University, Hangzhou 311121, China; Corresponding author

Yanmin Zhao

Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou 311121, China; Institute of Hematology, Zhejiang University, Hangzhou 311121, China; Corresponding author